357

A. Sharma et al., “S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research,” Journal of Clinical Psychiatry 78, no. 6 (June 2017): e656– e667, doi: 10.4088/JCP.16r11113.